 | • レポートコード：MRC2-11QY03140 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：食品・飲料 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバイオアクティブプロテイン・ペプチドのグローバル市場について調査・分析したレポートです。種類別（植物源、動物源）市場規模、用途別（機能性食品、機能性飲料、栄養補助食品、動物栄養、パーソナルケア、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バイオアクティブプロテイン・ペプチドの競争状況、市場シェア ・世界のバイオアクティブプロテイン・ペプチド市場：種類別市場規模 2015年-2020年（植物源、動物源） ・世界のバイオアクティブプロテイン・ペプチド市場：種類別市場規模予測 2021年-2026年（植物源、動物源） ・世界のバイオアクティブプロテイン・ペプチド市場：用途別市場規模 2015年-2020年（機能性食品、機能性飲料、栄養補助食品、動物栄養、パーソナルケア、その他） ・世界のバイオアクティブプロテイン・ペプチド市場：用途別市場規模予測 2021年-2026年（機能性食品、機能性飲料、栄養補助食品、動物栄養、パーソナルケア、その他） ・北米のバイオアクティブプロテイン・ペプチド市場分析：米国、カナダ ・ヨーロッパのバイオアクティブプロテイン・ペプチド市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバイオアクティブプロテイン・ペプチド市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバイオアクティブプロテイン・ペプチド市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバイオアクティブプロテイン・ペプチド市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Archer Daniels Midland Company、Kerry Group、Cargill、Omega Protein Corporation、Bunge、DuPont、Fonterra Co-operative Group、Royal DSM ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bio Active Protein and Peptides are peptide compounds that have beneficial or physiological effects on the life activities of living organisms. They are a class of peptides with a relative molecular mass of less than 6000 Da and various biological functions. Bioactive peptides have a variety of human metabolism and physiological regulation functions, easy to digest and absorb, and have the functions of promoting immunity, hormone regulation, antibacterial, antiviral, lowering blood pressure, lowering blood fat, etc.
Increasing health concerns and growing awareness of nutraceutical products among consumers are the primary factors expected to drive the global bio active protein and peptides market in the near future. Bio active protein and peptides display a number of physiological functionalities such as improving cardiovascular, nervous, gastrointestinal, and immune systems. A growing aging population and increasing incidence of chronic diseases among the people globally are other factors anticipated to drive revenue growth of the global bio active protein and peptides market. Also, a growing preference for bio active protein and peptides in cosmetics and personal care is likely to boost the global bio active protein and peptides market over the forecast period. However, stringent rules and regulations leading to increased operational costs and supply chain issues create a barrier for manufacturers operating in the global bio active protein and peptides market.
Market Analysis and Insights: Global Bio Active Protein and Peptides Market
The global Bio Active Protein and Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bio Active Protein and Peptides Scope and Market Size
Bio Active Protein and Peptides market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bio Active Protein and Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bio Active Protein and Peptides market is segmented into
Plant Source
Animal Source
Segment by Application, the Bio Active Protein and Peptides market is segmented into
Functional Food
Functional Beverages
Dietary Supplements
Animal Nutrition
Personal Care
Others
Regional and Country-level Analysis
The Bio Active Protein and Peptides market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bio Active Protein and Peptides market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bio Active Protein and Peptides Market Share Analysis
Bio Active Protein and Peptides market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bio Active Protein and Peptides business, the date to enter into the Bio Active Protein and Peptides market, Bio Active Protein and Peptides product introduction, recent developments, etc.
The major vendors covered:
Archer Daniels Midland Company
Kerry Group
Cargill
Omega Protein Corporation
Bunge
DuPont
Fonterra Co-operative Group
Royal DSM
1 Study Coverage
1.1 Bio Active Protein and Peptides Product Introduction
1.2 Market Segments
1.3 Key Bio Active Protein and Peptides Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bio Active Protein and Peptides Market Size Growth Rate by Type
1.4.2 Plant Source
1.4.3 Animal Source
1.5 Market by Application
1.5.1 Global Bio Active Protein and Peptides Market Size Growth Rate by Application
1.5.2 Functional Food
1.5.3 Functional Beverages
1.5.4 Dietary Supplements
1.5.5 Animal Nutrition
1.5.6 Personal Care
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bio Active Protein and Peptides Market Size, Estimates and Forecasts
2.1.1 Global Bio Active Protein and Peptides Revenue 2015-2026
2.1.2 Global Bio Active Protein and Peptides Sales 2015-2026
2.2 Global Bio Active Protein and Peptides, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bio Active Protein and Peptides Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bio Active Protein and Peptides Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bio Active Protein and Peptides Competitor Landscape by Players
3.1 Bio Active Protein and Peptides Sales by Manufacturers
3.1.1 Bio Active Protein and Peptides Sales by Manufacturers (2015-2020)
3.1.2 Bio Active Protein and Peptides Sales Market Share by Manufacturers (2015-2020)
3.2 Bio Active Protein and Peptides Revenue by Manufacturers
3.2.1 Bio Active Protein and Peptides Revenue by Manufacturers (2015-2020)
3.2.2 Bio Active Protein and Peptides Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bio Active Protein and Peptides Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bio Active Protein and Peptides Revenue in 2019
3.2.5 Global Bio Active Protein and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bio Active Protein and Peptides Price by Manufacturers
3.4 Bio Active Protein and Peptides Manufacturing Base Distribution, Product Types
3.4.1 Bio Active Protein and Peptides Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bio Active Protein and Peptides Product Type
3.4.3 Date of International Manufacturers Enter into Bio Active Protein and Peptides Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bio Active Protein and Peptides Market Size by Type (2015-2020)
4.1.1 Global Bio Active Protein and Peptides Sales by Type (2015-2020)
4.1.2 Global Bio Active Protein and Peptides Revenue by Type (2015-2020)
4.1.3 Bio Active Protein and Peptides Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bio Active Protein and Peptides Market Size Forecast by Type (2021-2026)
4.2.1 Global Bio Active Protein and Peptides Sales Forecast by Type (2021-2026)
4.2.2 Global Bio Active Protein and Peptides Revenue Forecast by Type (2021-2026)
4.2.3 Bio Active Protein and Peptides Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bio Active Protein and Peptides Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bio Active Protein and Peptides Market Size by Application (2015-2020)
5.1.1 Global Bio Active Protein and Peptides Sales by Application (2015-2020)
5.1.2 Global Bio Active Protein and Peptides Revenue by Application (2015-2020)
5.1.3 Bio Active Protein and Peptides Price by Application (2015-2020)
5.2 Bio Active Protein and Peptides Market Size Forecast by Application (2021-2026)
5.2.1 Global Bio Active Protein and Peptides Sales Forecast by Application (2021-2026)
5.2.2 Global Bio Active Protein and Peptides Revenue Forecast by Application (2021-2026)
5.2.3 Global Bio Active Protein and Peptides Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bio Active Protein and Peptides by Country
6.1.1 North America Bio Active Protein and Peptides Sales by Country
6.1.2 North America Bio Active Protein and Peptides Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bio Active Protein and Peptides Market Facts & Figures by Type
6.3 North America Bio Active Protein and Peptides Market Facts & Figures by Application
7 Europe
7.1 Europe Bio Active Protein and Peptides by Country
7.1.1 Europe Bio Active Protein and Peptides Sales by Country
7.1.2 Europe Bio Active Protein and Peptides Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bio Active Protein and Peptides Market Facts & Figures by Type
7.3 Europe Bio Active Protein and Peptides Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bio Active Protein and Peptides by Region
8.1.1 Asia Pacific Bio Active Protein and Peptides Sales by Region
8.1.2 Asia Pacific Bio Active Protein and Peptides Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bio Active Protein and Peptides Market Facts & Figures by Type
8.3 Asia Pacific Bio Active Protein and Peptides Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bio Active Protein and Peptides by Country
9.1.1 Latin America Bio Active Protein and Peptides Sales by Country
9.1.2 Latin America Bio Active Protein and Peptides Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bio Active Protein and Peptides Market Facts & Figures by Type
9.3 Central & South America Bio Active Protein and Peptides Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bio Active Protein and Peptides by Country
10.1.1 Middle East and Africa Bio Active Protein and Peptides Sales by Country
10.1.2 Middle East and Africa Bio Active Protein and Peptides Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bio Active Protein and Peptides Market Facts & Figures by Type
10.3 Middle East and Africa Bio Active Protein and Peptides Market Facts & Figures by Application
11 Company Profiles
11.1 Archer Daniels Midland Company
11.1.1 Archer Daniels Midland Company Corporation Information
11.1.2 Archer Daniels Midland Company Description and Business Overview
11.1.3 Archer Daniels Midland Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Archer Daniels Midland Company Bio Active Protein and Peptides Products Offered
11.1.5 Archer Daniels Midland Company Related Developments
11.2 Kerry Group
11.2.1 Kerry Group Corporation Information
11.2.2 Kerry Group Description and Business Overview
11.2.3 Kerry Group Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Kerry Group Bio Active Protein and Peptides Products Offered
11.2.5 Kerry Group Related Developments
11.3 Cargill
11.3.1 Cargill Corporation Information
11.3.2 Cargill Description and Business Overview
11.3.3 Cargill Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cargill Bio Active Protein and Peptides Products Offered
11.3.5 Cargill Related Developments
11.4 Omega Protein Corporation
11.4.1 Omega Protein Corporation Corporation Information
11.4.2 Omega Protein Corporation Description and Business Overview
11.4.3 Omega Protein Corporation Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Omega Protein Corporation Bio Active Protein and Peptides Products Offered
11.4.5 Omega Protein Corporation Related Developments
11.5 Bunge
11.5.1 Bunge Corporation Information
11.5.2 Bunge Description and Business Overview
11.5.3 Bunge Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bunge Bio Active Protein and Peptides Products Offered
11.5.5 Bunge Related Developments
11.6 DuPont
11.6.1 DuPont Corporation Information
11.6.2 DuPont Description and Business Overview
11.6.3 DuPont Sales, Revenue and Gross Margin (2015-2020)
11.6.4 DuPont Bio Active Protein and Peptides Products Offered
11.6.5 DuPont Related Developments
11.7 Fonterra Co-operative Group
11.7.1 Fonterra Co-operative Group Corporation Information
11.7.2 Fonterra Co-operative Group Description and Business Overview
11.7.3 Fonterra Co-operative Group Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Fonterra Co-operative Group Bio Active Protein and Peptides Products Offered
11.7.5 Fonterra Co-operative Group Related Developments
11.8 Royal DSM
11.8.1 Royal DSM Corporation Information
11.8.2 Royal DSM Description and Business Overview
11.8.3 Royal DSM Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Royal DSM Bio Active Protein and Peptides Products Offered
11.8.5 Royal DSM Related Developments
11.1 Archer Daniels Midland Company
11.1.1 Archer Daniels Midland Company Corporation Information
11.1.2 Archer Daniels Midland Company Description and Business Overview
11.1.3 Archer Daniels Midland Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Archer Daniels Midland Company Bio Active Protein and Peptides Products Offered
11.1.5 Archer Daniels Midland Company Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bio Active Protein and Peptides Market Estimates and Projections by Region
12.1.1 Global Bio Active Protein and Peptides Sales Forecast by Regions 2021-2026
12.1.2 Global Bio Active Protein and Peptides Revenue Forecast by Regions 2021-2026
12.2 North America Bio Active Protein and Peptides Market Size Forecast (2021-2026)
12.2.1 North America: Bio Active Protein and Peptides Sales Forecast (2021-2026)
12.2.2 North America: Bio Active Protein and Peptides Revenue Forecast (2021-2026)
12.2.3 North America: Bio Active Protein and Peptides Market Size Forecast by Country (2021-2026)
12.3 Europe Bio Active Protein and Peptides Market Size Forecast (2021-2026)
12.3.1 Europe: Bio Active Protein and Peptides Sales Forecast (2021-2026)
12.3.2 Europe: Bio Active Protein and Peptides Revenue Forecast (2021-2026)
12.3.3 Europe: Bio Active Protein and Peptides Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bio Active Protein and Peptides Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bio Active Protein and Peptides Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bio Active Protein and Peptides Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bio Active Protein and Peptides Market Size Forecast by Region (2021-2026)
12.5 Latin America Bio Active Protein and Peptides Market Size Forecast (2021-2026)
12.5.1 Latin America: Bio Active Protein and Peptides Sales Forecast (2021-2026)
12.5.2 Latin America: Bio Active Protein and Peptides Revenue Forecast (2021-2026)
12.5.3 Latin America: Bio Active Protein and Peptides Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bio Active Protein and Peptides Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bio Active Protein and Peptides Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bio Active Protein and Peptides Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bio Active Protein and Peptides Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bio Active Protein and Peptides Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bio Active Protein and Peptides Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bio Active Protein and Peptides Market Segments
Table 2. Ranking of Global Top Bio Active Protein and Peptides Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bio Active Protein and Peptides Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Plant Source
Table 5. Major Manufacturers of Animal Source
Table 6. Global Bio Active Protein and Peptides Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Bio Active Protein and Peptides Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Bio Active Protein and Peptides Sales by Regions 2015-2020 (K MT)
Table 9. Global Bio Active Protein and Peptides Sales Market Share by Regions (2015-2020)
Table 10. Global Bio Active Protein and Peptides Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Bio Active Protein and Peptides Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Bio Active Protein and Peptides Sales Share by Manufacturers (2015-2020)
Table 13. Global Bio Active Protein and Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Bio Active Protein and Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Active Protein and Peptides as of 2019)
Table 15. Bio Active Protein and Peptides Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Bio Active Protein and Peptides Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Bio Active Protein and Peptides Price (2015-2020) (USD/MT)
Table 18. Bio Active Protein and Peptides Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Bio Active Protein and Peptides Product Type
Table 20. Date of International Manufacturers Enter into Bio Active Protein and Peptides Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Bio Active Protein and Peptides Sales by Type (2015-2020) (K MT)
Table 23. Global Bio Active Protein and Peptides Sales Share by Type (2015-2020)
Table 24. Global Bio Active Protein and Peptides Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Bio Active Protein and Peptides Revenue Share by Type (2015-2020)
Table 26. Bio Active Protein and Peptides Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Bio Active Protein and Peptides Sales by Application (2015-2020) (K MT)
Table 28. Global Bio Active Protein and Peptides Sales Share by Application (2015-2020)
Table 29. North America Bio Active Protein and Peptides Sales by Country (2015-2020) (K MT)
Table 30. North America Bio Active Protein and Peptides Sales Market Share by Country (2015-2020)
Table 31. North America Bio Active Protein and Peptides Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Bio Active Protein and Peptides Revenue Market Share by Country (2015-2020)
Table 33. North America Bio Active Protein and Peptides Sales by Type (2015-2020) (K MT)
Table 34. North America Bio Active Protein and Peptides Sales Market Share by Type (2015-2020)
Table 35. North America Bio Active Protein and Peptides Sales by Application (2015-2020) (K MT)
Table 36. North America Bio Active Protein and Peptides Sales Market Share by Application (2015-2020)
Table 37. Europe Bio Active Protein and Peptides Sales by Country (2015-2020) (K MT)
Table 38. Europe Bio Active Protein and Peptides Sales Market Share by Country (2015-2020)
Table 39. Europe Bio Active Protein and Peptides Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Bio Active Protein and Peptides Revenue Market Share by Country (2015-2020)
Table 41. Europe Bio Active Protein and Peptides Sales by Type (2015-2020) (K MT)
Table 42. Europe Bio Active Protein and Peptides Sales Market Share by Type (2015-2020)
Table 43. Europe Bio Active Protein and Peptides Sales by Application (2015-2020) (K MT)
Table 44. Europe Bio Active Protein and Peptides Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Bio Active Protein and Peptides Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Bio Active Protein and Peptides Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Bio Active Protein and Peptides Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Bio Active Protein and Peptides Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Bio Active Protein and Peptides Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Bio Active Protein and Peptides Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Bio Active Protein and Peptides Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Bio Active Protein and Peptides Sales Market Share by Application (2015-2020)
Table 53. Latin America Bio Active Protein and Peptides Sales by Country (2015-2020) (K MT)
Table 54. Latin America Bio Active Protein and Peptides Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Bio Active Protein and Peptides Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Bio Active Protein and Peptides Revenue Market Share by Country (2015-2020)
Table 57. Latin America Bio Active Protein and Peptides Sales by Type (2015-2020) (K MT)
Table 58. Latin America Bio Active Protein and Peptides Sales Market Share by Type (2015-2020)
Table 59. Latin America Bio Active Protein and Peptides Sales by Application (2015-2020) (K MT)
Table 60. Latin America Bio Active Protein and Peptides Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Bio Active Protein and Peptides Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Bio Active Protein and Peptides Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Bio Active Protein and Peptides Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Bio Active Protein and Peptides Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Bio Active Protein and Peptides Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Bio Active Protein and Peptides Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Bio Active Protein and Peptides Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Bio Active Protein and Peptides Sales Market Share by Application (2015-2020)
Table 69. Archer Daniels Midland Company Corporation Information
Table 70. Archer Daniels Midland Company Description and Major Businesses
Table 71. Archer Daniels Midland Company Bio Active Protein and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Archer Daniels Midland Company Product
Table 73. Archer Daniels Midland Company Recent Development
Table 74. Kerry Group Corporation Information
Table 75. Kerry Group Description and Major Businesses
Table 76. Kerry Group Bio Active Protein and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Kerry Group Product
Table 78. Kerry Group Recent Development
Table 79. Cargill Corporation Information
Table 80. Cargill Description and Major Businesses
Table 81. Cargill Bio Active Protein and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Cargill Product
Table 83. Cargill Recent Development
Table 84. Omega Protein Corporation Corporation Information
Table 85. Omega Protein Corporation Description and Major Businesses
Table 86. Omega Protein Corporation Bio Active Protein and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Omega Protein Corporation Product
Table 88. Omega Protein Corporation Recent Development
Table 89. Bunge Corporation Information
Table 90. Bunge Description and Major Businesses
Table 91. Bunge Bio Active Protein and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Bunge Product
Table 93. Bunge Recent Development
Table 94. DuPont Corporation Information
Table 95. DuPont Description and Major Businesses
Table 96. DuPont Bio Active Protein and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. DuPont Product
Table 98. DuPont Recent Development
Table 99. Fonterra Co-operative Group Corporation Information
Table 100. Fonterra Co-operative Group Description and Major Businesses
Table 101. Fonterra Co-operative Group Bio Active Protein and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Fonterra Co-operative Group Product
Table 103. Fonterra Co-operative Group Recent Development
Table 104. Royal DSM Corporation Information
Table 105. Royal DSM Description and Major Businesses
Table 106. Royal DSM Bio Active Protein and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Royal DSM Product
Table 108. Royal DSM Recent Development
Table 109. Global Bio Active Protein and Peptides Sales Forecast by Regions (2021-2026) (K MT)
Table 110. Global Bio Active Protein and Peptides Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Bio Active Protein and Peptides Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Bio Active Protein and Peptides Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Bio Active Protein and Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 114. North America: Bio Active Protein and Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Bio Active Protein and Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 116. Europe: Bio Active Protein and Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Bio Active Protein and Peptides Sales Forecast by Region (2021-2026) (K MT)
Table 118. Asia Pacific: Bio Active Protein and Peptides Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Bio Active Protein and Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 120. Latin America: Bio Active Protein and Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Bio Active Protein and Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 122. Middle East and Africa: Bio Active Protein and Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Bio Active Protein and Peptides Players
Table 127. Bio Active Protein and Peptides Customers List
Table 128. Bio Active Protein and Peptides Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio Active Protein and Peptides Product Picture
Figure 2. Global Bio Active Protein and Peptides Sales Market Share by Type in 2020 & 2026
Figure 3. Plant Source Product Picture
Figure 4. Animal Source Product Picture
Figure 5. Global Bio Active Protein and Peptides Sales Market Share by Application in 2020 & 2026
Figure 6. Functional Food
Figure 7. Functional Beverages
Figure 8. Dietary Supplements
Figure 9. Animal Nutrition
Figure 10. Personal Care
Figure 11. Others
Figure 12. Bio Active Protein and Peptides Report Years Considered
Figure 13. Global Bio Active Protein and Peptides Market Size 2015-2026 (US$ Million)
Figure 14. Global Bio Active Protein and Peptides Sales 2015-2026 (K MT)
Figure 15. Global Bio Active Protein and Peptides Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Bio Active Protein and Peptides Sales Market Share by Region (2015-2020)
Figure 17. Global Bio Active Protein and Peptides Sales Market Share by Region in 2019
Figure 18. Global Bio Active Protein and Peptides Revenue Market Share by Region (2015-2020)
Figure 19. Global Bio Active Protein and Peptides Revenue Market Share by Region in 2019
Figure 20. Global Bio Active Protein and Peptides Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Bio Active Protein and Peptides Revenue in 2019
Figure 22. Bio Active Protein and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Bio Active Protein and Peptides Sales Market Share by Type (2015-2020)
Figure 24. Global Bio Active Protein and Peptides Sales Market Share by Type in 2019
Figure 25. Global Bio Active Protein and Peptides Revenue Market Share by Type (2015-2020)
Figure 26. Global Bio Active Protein and Peptides Revenue Market Share by Type in 2019
Figure 27. Global Bio Active Protein and Peptides Market Share by Price Range (2015-2020)
Figure 28. Global Bio Active Protein and Peptides Sales Market Share by Application (2015-2020)
Figure 29. Global Bio Active Protein and Peptides Sales Market Share by Application in 2019
Figure 30. Global Bio Active Protein and Peptides Revenue Market Share by Application (2015-2020)
Figure 31. Global Bio Active Protein and Peptides Revenue Market Share by Application in 2019
Figure 32. North America Bio Active Protein and Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Bio Active Protein and Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Bio Active Protein and Peptides Sales Market Share by Country in 2019
Figure 35. North America Bio Active Protein and Peptides Revenue Market Share by Country in 2019
Figure 36. U.S. Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Bio Active Protein and Peptides Market Share by Type in 2019
Figure 41. North America Bio Active Protein and Peptides Market Share by Application in 2019
Figure 42. Europe Bio Active Protein and Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Bio Active Protein and Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Bio Active Protein and Peptides Sales Market Share by Country in 2019
Figure 45. Europe Bio Active Protein and Peptides Revenue Market Share by Country in 2019
Figure 46. Germany Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Bio Active Protein and Peptides Market Share by Type in 2019
Figure 57. Europe Bio Active Protein and Peptides Market Share by Application in 2019
Figure 58. Asia Pacific Bio Active Protein and Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Bio Active Protein and Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Bio Active Protein and Peptides Sales Market Share by Region in 2019
Figure 61. Asia Pacific Bio Active Protein and Peptides Revenue Market Share by Region in 2019
Figure 62. China Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Bio Active Protein and Peptides Market Share by Type in 2019
Figure 85. Asia Pacific Bio Active Protein and Peptides Market Share by Application in 2019
Figure 86. Latin America Bio Active Protein and Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Bio Active Protein and Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Bio Active Protein and Peptides Sales Market Share by Country in 2019
Figure 89. Latin America Bio Active Protein and Peptides Revenue Market Share by Country in 2019
Figure 90. Mexico Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Bio Active Protein and Peptides Market Share by Type in 2019
Figure 97. Latin America Bio Active Protein and Peptides Market Share by Application in 2019
Figure 98. Middle East and Africa Bio Active Protein and Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Bio Active Protein and Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Bio Active Protein and Peptides Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Bio Active Protein and Peptides Revenue Market Share by Country in 2019
Figure 102. Turkey Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Bio Active Protein and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Bio Active Protein and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Bio Active Protein and Peptides Market Share by Type in 2019
Figure 109. Middle East and Africa Bio Active Protein and Peptides Market Share by Application in 2019
Figure 110. North America Bio Active Protein and Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Bio Active Protein and Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Bio Active Protein and Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Bio Active Protein and Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Bio Active Protein and Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Bio Active Protein and Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Bio Active Protein and Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Bio Active Protein and Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Bio Active Protein and Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Bio Active Protein and Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
バイオアクティブプロテインの世界市場（～2026年） Market Analysis and Insights: Global Bio Active Protein Market The global Bio Active Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Bio Active Protein Scope and Market Size Bio Active Protein market is segment…- TARDNA結合タンパク質43の世界市場（～2026年） Market Analysis and Insights: Global TAR DNA Binding Protein 43 Market The global TAR DNA Binding Protein 43 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global TAR DNA Binding Protein 43 Scope and Market Size TAR DNA Bind…
- 抗菌ペプチドの世界市場（～2026年） Antimicrobial peptides (AMPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate …
- ペプチドの世界市場（～2026年） Market Analysis and Insights: Global Peptides Market The global Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Peptides Scope and Market Size Peptides market is segmented by Type, and by Application. Players,…
- 機能性タンパク質の世界市場（～2026年） Functional proteins are a complex mixture of biologically active proteins that help support and maintain normal immune function. Market Analysis and Insights: Global Functional Protein Market The global Functional Protein market size is projected to reach US$ 4182.5 million by 2026, from US$ 3954 mi…